The effects of sunitinib on endometriosis

References

• Abbas MA, Disi AM, Taha MO. 2013. Sunitinib as an anti-endometriotic agent. European Journal of Pharmaceutical Sciences 49:732–736.
   PubMed Web of Science ®Google Scholar
• Basile A, Sica A, d’Aniello E, Breviario F, Garrido G, Castellano M et al. 1997. Characterization of the promoter for the human long pentraxin PTX3. Role of NF-kappaB in tumor necrosis factor-alpha and interleukin-1beta regulation. Journal of Biological Chemistry 272:8172–8178.
   PubMed Web of Science ®Google Scholar
• Bottazzi B, Garlanda C, Cotena A, Moalli F, Jaillon S, Deban L et al. 2009. The long pentraxin PTX3 as a prototypic humoral pattern recognition receptor: interplay with cellular innate immunity. Immunological Reviews 227:9–18.
   PubMed Web of Science ®Google Scholar
• Braundmeier AG, Fazleabas AT, Lessey BA, Guo H, Toole BP, Nowak RA. 2006. Extracellular matrix metalloproteinase inducer regulates metalloproteinases in human uterine endometrium. Journal of Clinical Endocrinology and Metabolism 91:2358–2365.
   PubMed Web of Science ®Google Scholar
• Bruse C, Radu D, Bergqvist A. 2004. In situ localization of mRNA for the fibrinolytic factors uPA, PAI-1 and uPAR in endometriotic and endometrial tissue. Molecular Human Reproduction 10:159–166.
   PubMed Web of Science ®Google Scholar
• Dabrosin C, Gyorffy S, Margetts P, Ross C, Gauldie J. 2002. Therapeutic effect of angiostatin gene transfer in a murine model of endometriosis. American Journal of Pathology 161:909–918.
   PubMed Web of Science ®Google Scholar
• Donnez J, Smoes P, Gillerot S, Casanas-Roux F, Nisolle M. 1998. Vascular endothelial growth factor (VEGF) in endometriosis. Human Reproduction 13:1686–1690.
   PubMed Web of Science ®Google Scholar
• Ethridge RT, Hashimoto K, Chung DH, Ehlers RA, Rajaraman S, Evers BM. 2002. Selective inhibition of NF-kB attenuates the severity of cerulein-induced acute pancreatitis. Journal of the American College of Surgeons 195:497–505.
   PubMed Web of Science ®Google Scholar
• Fazzini F, Peri G, Doni A, Dell’Antonio G, Dal Cin E, Bozzolo E et al. 2001. PTX3 in small-vessel vasculitides: An independent indicator of disease activity produced at sites of inflammation. Arthritis and Rheumatism 44:2841–2850.
   PubMed Web of Science ®Google Scholar
• Gallegos-Arreola MP, Valencia-Rodríguez LE, Puebla-Pérez AM, Figuera LE, Zúñiga-González GM. 2012. The TP53 16-bp Duplication polymorphism is enriched in endometriosis patients. Gynecologic and Obstetric Investigation 73:118–123.
   PubMed Web of Science ®Google Scholar
• Garlanda C, Bottazzi B, Bastone A, Mantovani A. 2005. Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annual Review of Immunology 23:337–366.
   PubMed Web of Science ®Google Scholar
• Griffioen AW, Molema G. 2000. Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacological Reviews 52:237–268.
   PubMed Web of Science ®Google Scholar
• Groothuis PG, Nap AW, Winterhager E, Grummer R. 2005. Vascular development in endometriosis. Angiogenesis 8:147–156.
   PubMedGoogle Scholar
• Hii LL, Rogers PA. 1998. Endometrial vascular and glandular expression of integrin alpha5beta3 in women with and without endometriosis. Human Reproduction 13:1030–1035.
   PubMed Web of Science ®Google Scholar
• Hughes E, Fedorkow D, Collins J, Vandekerckhove P. 2000. Ovulation suppression for endometriosis. Cochrane Database of Systematic Reviews(2):CD000155.
   Google Scholar
• Hull ML, Charnock-Jones DS, Chan CL, Bruner-Tran KL, Osteen KG, Tom BD et al. 2003. Antiangiogenic agents are effective inhibitors of endometriosis. Journal of Clinical Endocrinology and Metabolism 88: 2889–2899.
   PubMed Web of Science ®Google Scholar
• Keenan JA, Williams-Boyce PK, Massey PJ, Chen TT, Caudle MR, Bukovsky A. 1999. Regression of endometrial explants in a rat model of endometriosis treated with the immune modulators loxoribine and levamisole. Fertility and Sterility 72:135–141.
   PubMed Web of Science ®Google Scholar
• Kennedy S, Bergqvist A, Chapron C, D’Hooghe T, Dunselman G, Greb R et al. 2005. ESHRE guideline for the diagnosis and treatment of endometriosis. Human Reproduction 20:2698–2704.
   PubMed Web of Science ®Google Scholar
• Launay-Vacher V, Derey G. 2009. Hypertension and proteinuria: a class-effect of antiangiogenic therapies. Anti-Cancer Drugs 20:81–82.
   PubMed Web of Science ®Google Scholar
• Lazarus A, Keshet E. 2011. Vascular endothelial growth factor and vascular homeostasis. Proceedings of the American Thoracic Society 8:508–511.
   PubMedGoogle Scholar
• Linsky CB, Diamond MP, Cunningham T, Constantine B, DeCherney AH, diZerega GS. 1987. Adhesion reduction in the rabbit uterine horn model using an absorbable barrier, TC-7. Journal of Reproductive Medicine 32:17–20.
   PubMed Web of Science ®Google Scholar
• Maas JW, Le Noble FA, Dunselman GA, de Goeij AF, Struyker Boudier HA, Evers JL. 1999. The chick embryo chorioallantoic membrane as a model to investigate the angiogenic properties of human endometrium. Gynecologic and Obstetric Investigation 48:108–112.
   PubMed Web of Science ®Google Scholar
• Migliaretti G, Deltetto F, Delpiano EM, Bonino L, Berchialla P, Dalmasso P et al. 2012. Spatial Analysis of the Distribution of Endometriosis in Northwestern Italy. Gynecologic and Obstetric Investigation 73:135–140.
   PubMed Web of Science ®Google Scholar
• Miller SC, Huang R, Sakamuru S, Shukla SJ, Attene-Ramos MS, Shinn P et al. 2010. Identification of known drugs that act as inhibitors of NF-kappaB signaling and their mechanism of action. Biochemical Pharmacology 79:1272–1280.
   PubMed Web of Science ®Google Scholar
• Mori S, Cortes J, Kantarjian H, Zhang W, Andreef M, Ravandi F. 2008. Potential role of sorafenib in the treatment of acute myeloid leukemia. Leukemia and Lymphoma 49:2246–2255.
   PubMed Web of Science ®Google Scholar
• Morton DB, Griffiths PH. 1985. Guidelines on the recognition of pain, distress and discomfort in experimental animals and a hypothesis for assessment. Veterinary Record 116:431–436.
   PubMed Web of Science ®Google Scholar
• Nap AW, Dunselman GA, Griffioen AW, Mayo KH, Evers JL, Groothuis PG. 2005. Angiostatic agents prevent the development of endometriosis-like lesions in the chicken chorioallantoic membrane. Fertility and Sterility 83:793–795.
   PubMed Web of Science ®Google Scholar
• Ozer H, Boztosun A, Acmaz G, Atilgan R, Bozoklu O, Kosar MI. 2013. The efficacy of bevacizumab, sorafenib, and retinoic acid on rat endometriosis model. Scientific Reports 20:26–32.
   PubMed Web of Science ®Google Scholar
• Rodgers PA, D’Hooghe TM, Fazleabas A, Gargett CE, Giudice LC, Montgomery GW et al. 2009. Priorities for endometriosis research: recommendation from an international consensus workshop. Reproductive Sciences 16:335–346.
   PubMed Web of Science ®Google Scholar
• Schindler AE. 2004. Gonadotropin-releasing hormone agonists for prevention of postoperative adhesions: an overview. Gynecological Endocrinology 19:51–55.
   PubMed Web of Science ®Google Scholar
• Sharpe-Timms KL. 2002. Using rats as a research model for the study of endometriosis. Annals of the New York Academy of Sciences 955: 318–327.
   PubMed Web of Science ®Google Scholar
• Shifren JL, Tseng JF, Zaloudek CJ, Ryan IP, Meng YG, Ferrara N et al. 1996. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. Journal of Clinical Endocrinology and Metabolism 81:3112–3118.
   PubMed Web of Science ®Google Scholar
• Wingfield M, Macpherson A, Healy DL, Rogers PA. 1995. Cell proliferation is increased in the endometrium of women with endometriosis. Fertility and Sterility 64:340–346.
   PubMed Web of Science ®Google Scholar